Be part of our mission toPower Precision Proteomics to enable the earliest detection of disease.
Alamar is an Equal Opportunity Employer
We offer a competitive and comprehensive employee benefits package, including health, dental, vision, life insurance, a flexible spending plan, paid vacation, stock options and a 401(k) investment plan.
Building a world-class team
Our people are thekey to success
Building a company to improve human health is a major undertaking, and it requires a team of innovators that is dedicated to changing the world we live in. To get there, we strive to hire the best and build a high-performance team.
Our core philosophy is that our people are the key to success. We value integrity, excellence, passion, respect, inclusion, and collaboration. Our primary focus is to build a culture with the following goals:
Making customers ourtop priority
Fostering continuous learning and development
Building a culture of innovation
Encouraging out-of-the-box thinking and risk taking
Dr. Willams serves as the company's Chief Scientific Officer. Hewas previously Chief Medical Officer at Standard Biotools and at SomaLogic where he pioneered the discipline for discovery and validation of predictive, diagnostic and prognostic models using machine-learning applied to large-plex proteomics. 20 such tests were used for drug characterization, safety and efficacy when incorporated in clinical drug trials at Pharma/Biotech and 17 different multivariate tests were validated and translated into regulated healthcare uses. Prior to SomaLogic, Dr. Williams was at Pfizer in the UK and the USA as a clinical triallist in Translational Medicine, and subsequently as VP, Global Clinical Technology. He sat on the National Advisory Council for the National Institute of Biomedical Imaging and Bioengineering, the Executive Committee for the FNIH Biomarkers Consortium, and worked with FDA and PhRMA on developing evidentiary standards for biomarker qualification. Dr. William's medical training was in London, at Charing Cross and Westminster Medical School, followed by a PhD in medicine/physiology at the same institution and training in Radiology at the University of Newcastle Upon Tyne. Steve is co-inventor on 26 proteomics patents and author/coauthor on multiple foundational proteomics manuscripts.
Mr. McAnear serves as the company's Chief Financial Officer. He brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Mr. McAnear served for over 3 years as Tesla's VP of Worldwide Finance and Operations, supporting landmark initiatives such as the Model X and Model 3 launches and Solar City acquisition. He also held various roles at Apple and J&J earlier in his career and served as a naval officer and aviator for over 9 years.
#J-18808-Ljbffr